HomePTX • ASX
add
Prescient Therapeutics Ltd
Nakaraang pagsara
$0.044
Sakop ng araw
$0.044 - $0.044
Sakop ng taon
$0.037 - $0.11
Market cap
38.98M AUD
Average na Volume
646.01K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 886.29K | 51.05% |
Gastos sa pagpapatakbo | 2.49M | -11.37% |
Net na kita | -2.31M | -11.97% |
Net profit margin | -260.56 | 25.87% |
Kita sa bawat share | — | — |
EBITDA | -1.60M | 27.86% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.51M | -33.78% |
Kabuuang asset | 20.39M | -27.45% |
Kabuuang sagutin | 2.33M | 14.40% |
Kabuuang equity | 18.07M | — |
Natitirang share | 805.32M | — |
Presyo para makapag-book | 2.20 | — |
Return on assets | -19.63% | — |
Return on capital | -21.75% | — |
Cash Flow
Net change in cash
| (AUD) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.31M | -11.97% |
Cash mula sa mga operasyon | -1.96M | 6.45% |
Cash mula sa pag-invest | 4.00M | 150.00% |
Cash mula sa financing | 0.00 | -100.00% |
Net change in cash | 2.04M | 127.07% |
Malayang cash flow | -962.13K | 25.01% |
Tungkol
Prescient Therapeutics Ltd is a clinical stage oncology company. The company is focused on the development of a universal CAR-T platform, enhanced CAR-T cell manufacturing & function and on two small molecule drug targeted therapies. Wikipedia
Itinatag
May 22, 1986
Website
Mga Empleyado
3
